These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2924081

  • 1. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
    Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD.
    Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
    [Abstract] [Full Text] [Related]

  • 2. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
    Trist DG, Collins BA, Wood J, Kelly MG, Robertson AD.
    Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
    [Abstract] [Full Text] [Related]

  • 3. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
    Hamid-Bloomfield S, Payne AN, Petrovic AA, Whittle BJ.
    Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
    Hamid-Bloomfield S, Whittle BJ.
    Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
    [Abstract] [Full Text] [Related]

  • 5. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
    Rangachari PK, Betti PA, Prior ET, Roberts LJ.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
    [Abstract] [Full Text] [Related]

  • 6. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
    Keery RJ, Lumley P.
    Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
    [Abstract] [Full Text] [Related]

  • 7. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
    Lydford SJ, McKechnie KC, Leff P.
    Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
    [Abstract] [Full Text] [Related]

  • 8. Further studies on ocular responses to DP receptor stimulation.
    Woodward DF, Spada CS, Hawley SB, Williams LS, Protzman CE, Nieves AL.
    Eur J Pharmacol; 1993 Jan 19; 230(3):327-33. PubMed ID: 8440310
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ, McKechnie K.
    Br J Pharmacol; 1994 May 19; 112(1):133-6. PubMed ID: 8032634
    [Abstract] [Full Text] [Related]

  • 10. Functional characterization of the prostanoid DP receptor in human myometrium.
    Fernandes B, Crankshaw D.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):73-81. PubMed ID: 7498323
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S, Whittle BJ.
    Br J Pharmacol; 1986 Aug 05; 88(4):931-6. PubMed ID: 3017497
    [Abstract] [Full Text] [Related]

  • 12. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium.
    Liu YJ, Jackson DM, Blackham A, Leff P.
    Eur J Pharmacol; 1996 May 23; 304(1-3):117-22. PubMed ID: 8813592
    [Abstract] [Full Text] [Related]

  • 13. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
    Chan CL, Jones RL, Lau HY.
    Br J Pharmacol; 2000 Feb 23; 129(3):589-97. PubMed ID: 10711359
    [Abstract] [Full Text] [Related]

  • 14. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations.
    Liu YJ, Jackson DM, Blackham A.
    Eur J Pharmacol; 1996 May 15; 303(3):187-92. PubMed ID: 8813566
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
    Giles H, Bolofo ML, Lydford SJ, Martin GR.
    Br J Pharmacol; 1991 Oct 15; 104(2):541-9. PubMed ID: 1665742
    [Abstract] [Full Text] [Related]

  • 16. RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.
    Eglen RM, Whiting RL.
    J Pharm Pharmacol; 1989 May 15; 41(5):347-9. PubMed ID: 2569526
    [Abstract] [Full Text] [Related]

  • 17. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul 15; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 18. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 15; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 19. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
    Chen J, Woodward DF.
    Invest Ophthalmol Vis Sci; 1992 Oct 15; 33(11):3195-201. PubMed ID: 1328113
    [Abstract] [Full Text] [Related]

  • 20. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
    Senior J, Marshall K, Sangha R, Clayton JK.
    Br J Pharmacol; 1993 Feb 15; 108(2):501-6. PubMed ID: 8448599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.